Literature DB >> 21849425

Edaravone-loaded liposome eyedrops protect against light-induced retinal damage in mice.

Hiroki Shimazaki1, Kohei Hironaka, Takuya Fujisawa, Kazuhiro Tsuruma, Yuichi Tozuka, Masamitsu Shimazawa, Hirofumi Takeuchi, Hideaki Hara.   

Abstract

PURPOSE: To investigate the pharmacologic effects of eyedrops containing liposomes loaded with edaravone (3-methyl-1-phenyl-2-pyrazolin-5-1) against light-induced retinal damage in mice.
METHODS: Edaravone was incorporated into submicron-sized liposomes (ssLips) by the calcium acetate gradient method. Retinal damage in mice was induced in dark-adapted mice by exposure to white light at 8000 lux for 3 hours. Edaravone-loaded ssLips were dropped into the left eye just before and after light exposure and then three times daily for 5 days after light exposure. Retinal damage was evaluated by recording the scotopic electroretinogram (ERG) and measuring the thickness of the outer nuclear layer (ONL) and by terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining. The scavenging capacity of reactive oxygen species (ROS) of edaravone-loaded ssLips was determined using a murine cone photoreceptor cell line (661W). The human corneal and conjunctival cell lines were exposed to edaravone-loaded ssLips to determine cytotoxicity.
RESULTS: Eyedrop administration of edaravone-loaded ssLips significantly prevented both the decrease in a- and b-wave amplitudes of flash ERG and the shrinkage of the ONL compared with the control group (treated with empty ssLips) after 5 days of light exposure. The edaravone-loaded ssLips prevented the increase in the numbers of TUNEL-positive cells after 48 hours of light exposure. This marked protection was not found in the group treated with free edaravone. Edaravone-loaded ssLips showed a stronger inhibition of in vitro light-induced ROS production and cell death than did free edaravone. The ssLips showed little cytotoxicity toward ocular cell lines.
CONCLUSIONS: Edaravone-loaded ssLips protected against light-induced retinal dysfunction by eyedrop administration. Liposomal eyedrops may become one of the therapeutic candidates for drug delivery to posterior eye segments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21849425     DOI: 10.1167/iovs.11-7983

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

1.  Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis.

Authors:  Arzu Toruk Aksar; Nursen Yuksel; Mustafa Gok; Mustafa Cekmen; Yusuf Caglar
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

2.  Ocular drug delivery systems: An overview.

Authors:  Ashaben Patel; Kishore Cholkar; Vibhuti Agrahari; Ashim K Mitra
Journal:  World J Pharmacol       Date:  2013

3.  Fas ligand-Fas signaling participates in light-induced apoptotic death in photoreceptor cells.

Authors:  Qing Chang; Marcus E Peter; Michael A Grassi
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-20       Impact factor: 4.799

Review 4.  Lipid-based drug delivery systems in the treatment of wet age-related macular degeneration.

Authors:  Joanne D Du; Wye-Khay Fong; Suzanne Caliph; Ben J Boyd
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

Review 5.  Retinal Diseases Associated with Oxidative Stress and the Effects of a Free Radical Scavenger (Edaravone).

Authors:  Tomomi Masuda; Masamitsu Shimazawa; Hideaki Hara
Journal:  Oxid Med Cell Longev       Date:  2017-01-18       Impact factor: 6.543

6.  Edaravone-Encapsulated Agonistic Micelles Rescue Ischemic Brain Tissue by Tuning Blood-Brain Barrier Permeability.

Authors:  Qu Jin; Yu Cai; Sihan Li; Haoran Liu; Xingyu Zhou; Chunqiang Lu; Xihui Gao; Jun Qian; Jun Zhang; Shenghong Ju; Cong Li
Journal:  Theranostics       Date:  2017-02-08       Impact factor: 11.556

7.  RNA interference of GADD153 protects photoreceptors from endoplasmic reticulum stress-mediated apoptosis after retinal detachment.

Authors:  Hong Zhu; Jin Qian; Wenqiu Wang; Quan Yan; Ying Xu; Yuan Jiang; Lei Zhang; Fengqing Lu; Weiting Hu; Xi Zhang; Fenghua Wang; Xiaodong Sun
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

8.  Edaravone protect against retinal damage in streptozotocin-induced diabetic mice.

Authors:  Dongqing Yuan; Yidan Xu; Hui Hang; Xiaoyi Liu; Xi Chen; Ping Xie; Songtao Yuan; Weiwei Zhang; Xiaojun Lin; Qinghuai Liu
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

9.  Neuroprotection of a novel cyclopeptide C*HSDGIC* from the cyclization of PACAP (1-5) in cellular and rodent models of retinal ganglion cell apoptosis.

Authors:  Huanhuan Cheng; Yong Ding; Rongjie Yu; Jiansu Chen; Chunyun Wu
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

10.  Topical Use of Angiopoietin-like Protein 2 RNAi-loaded Lipid Nanoparticles Suppresses Corneal Neovascularization.

Authors:  Yukako Taketani; Tomohiko Usui; Tetsuya Toyono; Nobuyuki Shima; Seiichi Yokoo; Mikiko Kimakura; Satoru Yamagami; Shinichiro Ohno; Risako Onodera; Kohei Tahara; Hirofumi Takeuchi; Masahiko Kuroda
Journal:  Mol Ther Nucleic Acids       Date:  2016-03-08       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.